Physiological and pathological roles of a multi-ligand receptor CD36 in atherogenesis; insights from CD36-deficient patients.
about
Amyloid-β inhibits No-cGMP signaling in a CD36- and CD47-dependent mannerLuminal lipid regulates CD36 levels and downstream signaling to stimulate chylomicron synthesisCD36 is important for fatty acid and cholesterol uptake by the proximal but not distal intestineOily Fish Consumption Modifies the Association between CD36 rs6969989 Polymorphism and Lipid Profiles in Korean WomenA vascular biology network model focused on inflammatory processes to investigate atherogenesis and plaque instability.Association of polymorphisms in platelet and hemostasis system genes with acute myocardial infarctionCellular fatty acid uptake: a pathway under construction.CD36, a scavenger receptor implicated in atherosclerosis.Variants of the CD36 gene and metabolic syndrome in Boston Puerto Rican adultsCommon CD36 SNPs reduce protein expression and may contribute to a protective atherogenic profileOpposite regulation of CD36 ubiquitination by fatty acids and insulin: effects on fatty acid uptake.Structure-function of CD36 and importance of fatty acid signal transduction in fat metabolismPreliminary studies on CD36 gene in type 2 diabetic patients from north IndiaCommon variation in the CD36 (fatty acid translocase) gene is associated with left-ventricular mass.Cleavage and reduced CD36 ectodomain density on heart and spleen macrophages in the spontaneously hypertensive rat.CD36 genotype associated with ischemic stroke in Chinese Han.Role of the gut in lipid homeostasisCardiac lipotoxicity: molecular pathways and therapeutic implications.Myocardial insulin action and the contribution of insulin resistance to the pathogenesis of diabetic cardiomyopathy.Peroxisome proliferator-activated receptors--from active regulators of macrophage biology to pharmacological targets in the treatment of cardiovascular disease.CD36 regulates oxidative stress and inflammation in hypercholesterolemic CKDVariants in the CD36 gene associate with the metabolic syndrome and high-density lipoprotein cholesterolChylomicron remnants are increased in the postprandial state in CD36 deficiency.CD36 haplotypes are associated with lipid profile in normal-weight subjects.Protein-mediated Fatty Acid Uptake in the Heart.Hyperlipidemia: a new therapeutic target for diabetic neuropathy.Oxidation-specific epitopes are danger-associated molecular patterns recognized by pattern recognition receptors of innate immunity.Parkin reinvents itself to regulate fatty acid metabolism by tagging CD36.The pathophysiology of intestinal lipoprotein production.Dyslipidemia Part 1--Review of Lipid Metabolism and Vascular Cell Physiology.Macrophage heterogeneity and cholesterol homeostasis: classically-activated macrophages are associated with reduced cholesterol accumulation following treatment with oxidized LDL.Higher chylomicron remnants and LDL particle numbers associate with CD36 SNPs and DNA methylation sites that reduce CD36.Regulation of fatty acid uptake into tissues: lipoprotein lipase- and CD36-mediated pathwaysThe Human Scavenger Receptor CD36: glycosylation status and its role in trafficking and functionInsight into the mechanism of lipids binding and uptake by CD36 receptorHigh sCD36 plasma level is associated with steatosis and its severity in patients with genotype 1 chronic hepatitis C.Intestinal lipid absorption, GLP-2, and CD36: still more mysteries to moving fat.CD36 Is a Marker of Human Adipocyte Progenitors with Pronounced Adipogenic and Triglyceride Accumulation Potential.Oleoylethanolamide: The role of a bioactive lipid amide in modulating eating behaviour.Plasma sCD36 is associated with markers of atherosclerosis, insulin resistance and fatty liver in a nondiabetic healthy population.
P2860
Q28476620-E9C02410-FEDF-4684-BD34-FA680B4DE945Q28578553-E8A26003-CBEF-4E80-A16E-8B99B7E46E91Q28588690-23F0460F-CCED-47F3-ACAD-D0B19A1D9259Q28822076-0E811F71-9B32-45F5-BC93-70BC4FCD1A80Q30597305-FAC5DBFF-E323-47E2-8872-D6A5EE111303Q33653519-A1811EF5-125D-4269-87BE-C6A1C8336620Q33753883-C644B28E-0485-4DF8-8E6B-4046880533D8Q33844864-56E09AEF-CD2B-4C2A-9322-44660DC08D82Q34073895-0EA59B50-1977-493F-9CE6-F2E85DAEF1A0Q34399408-788E20CF-07D0-4603-93B6-7B5E5E2D6C82Q34763366-A09BA6C7-AC9A-4F2D-B96A-328878F50D5CQ35087570-2C271C13-60A0-4C27-990A-F7EC3071D4C8Q35210118-E0E6B12E-BBE9-4F86-BA00-51E8D27C0F0BQ35679426-D37CB453-5A14-499B-97C8-002AE97F4A96Q36274816-E4AAE1E6-B5BC-4E2D-AD8E-6412E720A9E6Q36317868-20D81AFA-9F66-4300-A744-30015DCAFFE1Q36660888-6C985E32-4ABF-4B67-BA66-BF660D16C55FQ36824112-E2BE098D-7E34-4895-9E10-57B7EC236F9CQ36844816-AD241B87-DABE-4C05-A9DA-735917E7F582Q37016305-C0DECB2A-B89E-41DB-B2A2-9752C0C23523Q37123263-EF168FC0-E063-4C14-B809-1606BB4DF48AQ37127230-DF083449-0295-47D4-B623-E52A6599C7CFQ37151867-40ECB6E6-298C-4B2F-88B9-F75B300D3EAEQ37348385-32D379EC-D23F-4180-A16F-7C1AC16F7385Q37414786-DA3980B7-CB25-4B0E-9109-5281CCAF4A55Q37659233-DDAE975F-BFEE-4C71-AFC7-57255D0D51E4Q37830940-13390F90-01E9-4CD4-9FF0-5FB0A9FDA09FQ38271872-903075C5-02F8-4C85-BC27-BB95B66BAD98Q38410893-E502811A-FBB5-4597-967A-43C3BDBC0647Q38777318-E60F3A4A-74C5-4153-A07F-DC043EA9D940Q39246963-8F12B2DF-8452-4659-AF4B-E23DA01163D9Q40545995-E57D6124-B63E-4EF5-BC00-BCDA7556954EQ41787315-B2576514-BB1E-40B4-AF66-10C23631904DQ42025674-88944A5D-6DF9-409A-B718-D2BEDB75C1A6Q42379208-0AA1E3F9-53B1-45A1-A948-E97A84B51C52Q42988922-EFAAC83B-4D62-402A-BE66-EAA300F152E7Q43149643-F317ACD3-FB59-4CC5-B589-DD4F6C95D059Q48194105-5C1BB997-2897-41EC-91B3-F91C855811ABQ50074099-56354252-0CE6-4F4E-9E4C-54CF21F5FAC2Q51535629-6FE97BFA-C682-40B0-95D1-E756FDF127FA
P2860
Physiological and pathological roles of a multi-ligand receptor CD36 in atherogenesis; insights from CD36-deficient patients.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
Physiological and pathological ...... from CD36-deficient patients.
@en
Physiological and pathological ...... from CD36-deficient patients.
@nl
type
label
Physiological and pathological ...... from CD36-deficient patients.
@en
Physiological and pathological ...... from CD36-deficient patients.
@nl
prefLabel
Physiological and pathological ...... from CD36-deficient patients.
@en
Physiological and pathological ...... from CD36-deficient patients.
@nl
P2093
P1476
Physiological and pathological ...... from CD36-deficient patients.
@en
P2093
Ken-ichi Hirano
Masato Ishigami
Mohamed Janabi
Naohiko Sakai
Shizuya Yamashita
Takahiro Kuwasako
Yumiko Toyama
P2888
P356
10.1007/S11010-005-9031-4
P577
2007-05-01T00:00:00Z